GORAB
protein-codinggolgin, RAB6 interacting
Gene summary
This gene encodes a member of the golgin family, a group of coiled-coil proteins localized to the Golgi. The encoded protein may function in the secretory pathway. The encoded protein, which also localizes to the cytoplasm, was identified by interactions with the N-terminal kinase-like protein, and thus it may function in mitosis. Mutations in this gene have been associated with geroderma osteodysplastica. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]
- SCYL1BP1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~22.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009271
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009271
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009271
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009271
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009271
Submitter: ClinGen
*GORAB* was first reported in relation to geroderma osteodysplastica (GO), in 2008 (Hennies et al, PMID: 18997784). GO is an autosomal recessive segmental progeroid disorder that affects the skin, connective tissues, and bone. It is characterized by wrinkled skin, joint laxity, a prematurely aged facial appearance, severe osteoporosis leading to frequent fractures, malar and mandibular hypoplasia, variable growth retardation, and mild intellectual disability in some cases. GO is the only condition known to result from variants in *GORAB*. Twelve variants (7 nonsense, 3 frameshift, 2 missense) that have been reported in ten probands in four publications (Hennies et al, 2008 PMID: 18997784; Al-Dosari & Alkuraya, 2009, PMID: 19681135; Takeda et al, PMID: 28807865, 2017; Saad et al, 2024, PMID: 39619733) are included in this curation. Segregation evidence from Mennonite families was also included. A founder variant, c.367G>T (p.Glu123Ter), has been identified in that population (Hennies et al, 2008 PMID: 18997784). More evidence is available in the literature, but the maximum score for genetic evidence (>12 points) has been reached. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by experimental evidence including biochemical function and mouse models (total 2 points). *GORAB* encodes a protein that localizes to the trans Golgi where it interacts with RAB6, regulates the level of active TGF-β, and stabilizes the COPI complex. It has been shown to be important in COPI-mediated retrograde trafficking of transGolgi enzymes, including glycosyltransferases. Loss of *GORAB* function leads to defective protein glycosylation and disorganization of the extracellular matrix, consistent with the clinical phenotype. Null mouse models die early in life and do not have a skin phenotype. Mouse models with conditional loss of Gorab in osteoblasts recapitulate the bone phenotype in human, with osteoporosis and multiple long bone fractures (Yang et al, 2017, PMID: 29108851; Chan et al, 2018, PMID: 29561836; Chan et al, 2024, 39234801). In summary, there is definitive evidence supporting the relationship between *GORAB* and geroderma osteodysplastica, and autosomal recessive segmental progeroid condition. This has been repeatedly demonstrated in both research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on July 3, 2025 (SOP Version #11].
Inheritance Pattern: AR
Disease ID:MONDO:0009271
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009271
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Dermatologic; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GORAB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_152281.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 114 | 2 | 116 | |||
| missense | 1 | 118 | 7 | 126 | ||
| nonsense | 10 | 4 | 2 | 16 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 18 | 5 | 1 | 24 | ||
| splice donor/acceptor (+/-2bp) | 4 | 1 | 5 | |||
| Total | 29 | 14 | 123 | 121 | 2 | 289 |
Highest pathogenic variant AF is 0.00014994027
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_689494.3 | 5 | MANE Select | |
| Ensembl | ENSP00000356737.4 | 5 | MANE Select | |
| RefSeq | NP_001139511.2 | 4 | Standard | |
| RefSeq | NP_001307181.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- p53 signaling pathway - Homo sapiens (human)
Biological Process
- hair follicle morphogenesis
- positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning
- non-motile cilium assembly
Molecular Function
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- nucleolus
- cytoplasm
- Golgi apparatus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367763
- Coding exons
- 5
- Length
- 21318
- Individuals with no LoFs
- 125704
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 42
- Defined
- 125746
- p
- 0.000167
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.180 | 223 | 216 | 1.03 | 0.0000123 | 2575 |
| Missense (PolyPhen) | 64 | 71.77 | 0.89173 | 858 | ||
| Synonymous | -1.08 | 91 | 78.8 | 1.16 | 0.00000429 | 751 |
| Loss of Function | 1.61 | 11 | 18.4 | 0.596 | 0.00000111 | 185 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00016 | 0.00013 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00082 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Geroderma osteodysplasticum (GO) [MIM:231070]: A rare autosomal recessive disorder characterized by lax, wrinkled skin, joint laxity and a typical face with a prematurely aged appearance. Skeletal signs include severe osteoporosis leading to frequent fractures, malar and mandibular hypoplasia and a variable degree of growth retardation. {ECO:0000269|PubMed:18997784}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0895
Intolerance Scores
- LoFtool
- 0.887
- RVIS EVS
- -0.47
- RVIS percentile EVS
- 23.43
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.239
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |